Cargando…
Hepatitis viruses in Ethiopia: a systematic review and meta-analysis
BACKGROUND: The existing seroepidemiological data on viral hepatitis in Ethiopia showed a wide variation in prevalence pattern and the clinical and public health burden have been underestimated. The aim of this systematic review and meta-analysis was to provide a clear and comprehensive estimation o...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5168848/ https://www.ncbi.nlm.nih.gov/pubmed/27993129 http://dx.doi.org/10.1186/s12879-016-2090-1 |
_version_ | 1782483424737492992 |
---|---|
author | Belyhun, Yeshambel Maier, Melanie Mulu, Andargachew Diro, Ermias Liebert, Uwe Gerd |
author_facet | Belyhun, Yeshambel Maier, Melanie Mulu, Andargachew Diro, Ermias Liebert, Uwe Gerd |
author_sort | Belyhun, Yeshambel |
collection | PubMed |
description | BACKGROUND: The existing seroepidemiological data on viral hepatitis in Ethiopia showed a wide variation in prevalence pattern and the clinical and public health burden have been underestimated. The aim of this systematic review and meta-analysis was to provide a clear and comprehensive estimation of viral hepatitis epidemiology and the potential clinical burdens in Ethiopia. METHODS: A comprehensive literature search was carried out from five decades (1968–2015) published studies from biomedical databases; PubMed, Google scholar, Medline and Web of Science. RESULTS: The overall pooled prevalence of hepatitis B virus (HBV) was 7.4% (95%CI: 6.5–8.4). The pooled prevalence among subgroups showed 5.2% (95%CI: 3.7–7.4) in human immunodeficiency virus (HIV) infected individuals, 8.0% (95%CI: 5.9–10.7) in community based studies, 8.4% (95%CI: 5.4–12.7) in blood donors, 11.0% (95%CI: 7.5–15.9) in immigrants and 6.9% (95%CI: 5.6–8.5) in other groups. Among study parameters considered during meta-regression analysis, only study years were associated with a decreasing HBV prevalence rate over time. The overall pooled prevalence of anti-hepatitis C virus antibody (anti-HCV) was 3.1% (95%CI: 2.2–4.4). Unlike HBV, the anti-HCV prevalence in HIV infected individuals was higher (5.5%, 95%CI: 3.8–7.8%, p = 0.01) than the prevalence observed in the other subgroup of study population. Although relatively few data were available, hepatitis virus A (HAV), D (HDV) and E (HEV) were also circulated in Ethiopia. CONCLUSIONS: This review indicates that all types of viral hepatitis origins are endemic in Ethiopia. Adapting a recommended diagnostic and treatment algorithm of viral hepatitis in the routine healthcare systems and implementing prevention and control policies in the general population needs an urgent attention. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12879-016-2090-1) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5168848 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-51688482016-12-28 Hepatitis viruses in Ethiopia: a systematic review and meta-analysis Belyhun, Yeshambel Maier, Melanie Mulu, Andargachew Diro, Ermias Liebert, Uwe Gerd BMC Infect Dis Research Article BACKGROUND: The existing seroepidemiological data on viral hepatitis in Ethiopia showed a wide variation in prevalence pattern and the clinical and public health burden have been underestimated. The aim of this systematic review and meta-analysis was to provide a clear and comprehensive estimation of viral hepatitis epidemiology and the potential clinical burdens in Ethiopia. METHODS: A comprehensive literature search was carried out from five decades (1968–2015) published studies from biomedical databases; PubMed, Google scholar, Medline and Web of Science. RESULTS: The overall pooled prevalence of hepatitis B virus (HBV) was 7.4% (95%CI: 6.5–8.4). The pooled prevalence among subgroups showed 5.2% (95%CI: 3.7–7.4) in human immunodeficiency virus (HIV) infected individuals, 8.0% (95%CI: 5.9–10.7) in community based studies, 8.4% (95%CI: 5.4–12.7) in blood donors, 11.0% (95%CI: 7.5–15.9) in immigrants and 6.9% (95%CI: 5.6–8.5) in other groups. Among study parameters considered during meta-regression analysis, only study years were associated with a decreasing HBV prevalence rate over time. The overall pooled prevalence of anti-hepatitis C virus antibody (anti-HCV) was 3.1% (95%CI: 2.2–4.4). Unlike HBV, the anti-HCV prevalence in HIV infected individuals was higher (5.5%, 95%CI: 3.8–7.8%, p = 0.01) than the prevalence observed in the other subgroup of study population. Although relatively few data were available, hepatitis virus A (HAV), D (HDV) and E (HEV) were also circulated in Ethiopia. CONCLUSIONS: This review indicates that all types of viral hepatitis origins are endemic in Ethiopia. Adapting a recommended diagnostic and treatment algorithm of viral hepatitis in the routine healthcare systems and implementing prevention and control policies in the general population needs an urgent attention. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12879-016-2090-1) contains supplementary material, which is available to authorized users. BioMed Central 2016-12-19 /pmc/articles/PMC5168848/ /pubmed/27993129 http://dx.doi.org/10.1186/s12879-016-2090-1 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Belyhun, Yeshambel Maier, Melanie Mulu, Andargachew Diro, Ermias Liebert, Uwe Gerd Hepatitis viruses in Ethiopia: a systematic review and meta-analysis |
title | Hepatitis viruses in Ethiopia: a systematic review and meta-analysis |
title_full | Hepatitis viruses in Ethiopia: a systematic review and meta-analysis |
title_fullStr | Hepatitis viruses in Ethiopia: a systematic review and meta-analysis |
title_full_unstemmed | Hepatitis viruses in Ethiopia: a systematic review and meta-analysis |
title_short | Hepatitis viruses in Ethiopia: a systematic review and meta-analysis |
title_sort | hepatitis viruses in ethiopia: a systematic review and meta-analysis |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5168848/ https://www.ncbi.nlm.nih.gov/pubmed/27993129 http://dx.doi.org/10.1186/s12879-016-2090-1 |
work_keys_str_mv | AT belyhunyeshambel hepatitisvirusesinethiopiaasystematicreviewandmetaanalysis AT maiermelanie hepatitisvirusesinethiopiaasystematicreviewandmetaanalysis AT muluandargachew hepatitisvirusesinethiopiaasystematicreviewandmetaanalysis AT diroermias hepatitisvirusesinethiopiaasystematicreviewandmetaanalysis AT liebertuwegerd hepatitisvirusesinethiopiaasystematicreviewandmetaanalysis |